Sarah George, M.D., Associate Professor of Infectious Diseases, Allergy & Immunology, is Principal Investigator of the SLU trial to study three different doses of a Zika vaccine. The trial is part of a larger three-part investigation of the vaccine, which was developed by the Walter Reed Army Institute of Research.

Investigators recently published early Phase 1 results in Lancet, which show that the vaccine is well tolerated and has produced an immune response in over 90% of study volunteers.

For more information, read the full article in Newslink.